During his remarks at the White House today, President Trump struggled to explain why he pardoned a notorious drug trafficker. Trump stated, "That was a Biden witch hunt." Donald Trump's approval ...

President Donald Trump and his Pentagon chief say U.S. military strikes on suspected drug boats in waters off Latin America are saving lives by preventing narcotics from reaching America’s shores. But ...

Four people are facing charges after a community in Anne Arundel County, Maryland, raised concerns about drug activity, according to police. In October, officers began investigating in Brooklyn Park, ...

President Donald Trump says Americans could soon pay far less for GLP-1 medications used for diabetes, obesity, and heart disease. He announced that his administration has secured a deal to bring ...

More than 70 arrests were made and nearly 10 lbs. were seized in just over a week in San Francisco, according to the police department on Friday. Police said these arrests come as the department ...

Some people taking popular new diabetes and weight-loss drugs including Ozempic, Wegovy, Zepbound and Mounjaro have reported reduced cravings for substances besides food. The medications seem to ...

A Northwestern team transformed a common chemotherapy drug into a powerful, targeted cancer therapy using spherical nucleic acids. The redesign dramatically boosted drug absorption and cancer-killing ...

Novartis is pulling back the curtain on late-stage Sjögren’s wins, revealing an edge for its investigational monoclonal antibody ianalumab over placebo in both studies. “Clearly, with Sjögren's having ...

ST. LOUIS — Downtown St. Louis has been grappling with ongoing concerns about open drug use and public safety in its parks. Last month, the city temporarily closed the park at 14th and Pine Streets ...

Basel, October 29, 2025 – Novartis today presented new ianalumab data in Sjögren’s disease, the second most prevalent rheumatic autoimmune disease 2, at a late-breaker presentation during the American ...

Something just wasn’t adding up when Dr. Mehmet Oz — the current administrator for the Centers for Medicare and Medicaid service — tried to explain president Trump’s new drug pricing scheme. That ...